Close Menu

Microarrays & Multiplexing

News on microarrays, multiplexing, genotyping, cytogenetics, gene expression profiling in genetics, genomics, and molecular diagnostics.

Agilent said its qualitative assay is used for the postnatal diagnosis of copy-number alterations and copy-neutral loss of heterozygosity from DNA.

One of the tests is customized for use on Bioneer's automated ExiStation instrument, while the other is compatible with various standard PCR systems.

The RT-PCR-based test is designed for the qualitative detection of SARS-CoV-2 nucleic acid in upper and lower respiratory specimens.

BioFire has submitted a 39-target test to the US Food and Drug Administration. OpGen also has a test in development.

The firm recently described circumstances in which the fraction of host or donor DNA could be altered, and plans new approaches to data interpretation.